eCite Digital Repository

Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies

Citation

Eapen, MS and Sharma, P and Thompson, IE and Lu, W and Myers, S and Hansbro, PM and Sohal, SS, Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies, Laboratory Investigation, 99, (2) pp. 150-157. ISSN 0023-6837 (2019) [Refereed Article]


Preview
PDF (Author version)
339Kb
  

Copyright Statement

Copyright 2018 United States & Canadian Academy of Pathology

DOI: doi:10.1038/s41374-018-0146-0

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive and devastating chronic lung condition that has a significant global burden, both medically and financially. Currently there are no medications that can alter the course of disease. At best, the drugs in clinical practice provide symptomatic relief to suffering patients by alleviating acute exacerbations. Most of current clinical research activities are in late severe disease with lesser attention given to early disease manifestations. There is as yet, a lack of understanding of the underlying mechanisms of disease progression and the molecular switches that are involved in their manifestation. Small airway fibrosis and obliteration are known to cause fixed airflow obstruction in COPD, and the consequential damage to the lung has an early onset. So far, there is little evidence of the mechanisms that underlie this aspect of pathology. However, emerging research confirms that airway epithelial reprogramming or epithelial to mesenchymal transition (EMT) is a key mechanism that drives fibrotic remodelling changes in smokers and patients with COPD. A recent study by Lai et al. further highlights the importance of EMT in smoking-related COPD pathology. The authors identify HB-EGF, an EGFR ligand, as a key driver of EMT and a potential new therapeutic target for the amelioration of EMT and airway remodelling. There are also wider implications in lung cancer prophylaxis, which is another major comorbidity associated with COPD. We consider that improved molecular understanding of the intricate pathways associated with epithelial cell plasticity in smokers and patients with COPD will have major therapeutic implications.

Item Details

Item Type:Refereed Article
Keywords:COPD, IPF, epithelium, fibrosis, EMT, cancer, ICS, inflammation
Research Division:Medical and Health Sciences
Research Group:Cardiorespiratory Medicine and Haematology
Research Field:Respiratory Diseases
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Respiratory System and Diseases (incl. Asthma)
UTAS Author:Eapen, MS (Mr Mathew Eapen)
UTAS Author:Thompson, IE (Miss Isobel Thompson)
UTAS Author:Lu, W (Dr Monica Lu)
UTAS Author:Myers, S (Dr Stephen Myers)
UTAS Author:Sohal, SS (Dr Sukhwinder Sohal)
ID Code:129452
Year Published:2019
Web of Science® Times Cited:1
Deposited By:Health Sciences
Deposited On:2018-11-30
Last Modified:2019-08-23
Downloads:4 View Download Statistics

Repository Staff Only: item control page